IVA Inventiva S.A.
Healthcare$5.07-2.69%ClosedMarket Cap: $263.5M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
-103.53
P/S
143.78
EV/EBITDA
-4.54
DCF Value
$-0.15
FCF Yield
-16.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
35.1%
Operating Margin
-3037.3%
Net Margin
-7899.6%
ROE
1870.4%
ROA
-141.9%
ROIC
-66.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $28.8K | -4062.1% | $-74.1M | $-176.9M | $— | — |
| FY null | $4.5M | 33.7% | $-130.9M | $-340.2M | $— | — |
| Q2 null | $4.5M | 61.7% | $-56.8M | $-175.9M | $— | — |
| Q4 null | $6.5M | 108.1% | $-45.3M | $-135.2M | $— | — |
| FY null | $9.2M | 100.0% | $-97.6M | $-184.2M | $— | — |
| Q2 null | $2.7M | 80.8% | $-52.2M | $-49.0M | $— | — |
| Q4 null | $16.5M | 96.6% | $-47.7M | $-55.2M | $— | — |
| FY null | $17.5M | 100.1% | $-102.7M | $-110.4M | $— | — |
| Q2 null | $6.6M | 93.1% | $-55.0M | $-55.3M | $— | — |
| Q4 null | $15.4M | 96.9% | $-23.6M | $-24.8M | $— | — |
| FY null | $12.2M | 140.1% | $-57.1M | $-54.3M | $— | — |
| Q2 null | $67.0K | -677.6% | $-36.5M | $-29.5M | $— | — |